Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Proactive Investors" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Proactive Investors for you to read. Along with our medical data and news we also list Proactive Investors Clinical Trials, which are updated daily. BioPortfolio also has a large database of Proactive Investors Companies for you to search.
Cannabis stocks stabilized in Canada on Friday after doing significant drops and bumps this week on the back of a host of news in the country that is nearing recreational legalized marijuana in Oct.
Small cap names on the move are: Evolus Inc (NASDAQ:EOLS), Zoë's Kitchen Inc (NYSE:ZOES), America’s Car-Mart Inc (NASDAQ:CRMT), Zion Oil & Gas Inc (NASDAQ:ZN).
Since reporting its full-year results on July 10, the AIM-listed shares have rallied over 38% in the past month to 3.65p currently, taking year-to-date gains to a third
Jonathan Tobin, investment director at Arix Bioscience Plc (LON:ARIX), discusses with Proactive's Andrew Scott their decision to increase their stake and in doing so becoming the largest shareholder in Artios Pharma. Artios is developing DNA damage response technology to treat cancer. Tobin says the new funds will help Artios advance its portfolio of small molecule DDR programmes - inc...
Lancor Scientific's chief operating officer Gopal Rao and chief medical officer Roland Schlesinger discuss with Proactive Investors some of the upcoming milestones for their Tumour Trace technology. Roland Schlesinger's a specialist in health technology assessment - essentially analysing pharmaceuticals or medical technologies for efficiency and efficacy. ''The great thing about the technolo...
The Cincinnati-based company has developed a novel delivery technology that helps achieve more precise dosing — a tricky undertaking when it comes to medical cannabis
Sensyne issued shares at 175p as part of its initial public offering, and those shares are already trading at 187.5p – a gain of 7%
Auto injector drug device combination approved by the FDA
Chief medical officer David Huang will give a presentation on Motif’s next generation antibiotic on September 5 at the conference, which is being held in Lisbon
Dr Cath O'Neill, chief executive of SkinBioTherapeutics PLC (LON:SBTX), tells Proactive's Andrew Scott their recent work's been focusing on turning the technology into a real commercial proposition. ''We've made some very good progress to that end .. what we've been able to report this morning is that we've achieved commercial levels of scale-up and we've been able to freeze-dry the technology...
Small cap names on the move today are: Evoke Pharma Inc (NASDAQ:EVOK), Ferroglobe PLC (NASDAQ:GSM), Pain Therapeutics Inc (NASDAQ:PTIE), JC Penney Inc (NYSE:JCP).
Crypto trading platform Sfox has raised a total of US$23mln through venture capital firms and crypto investors
The star fund manager has endured a difficult time with his various funds since setting up his own firm in 2014; can Sensyne Health, which joins AIM tomorrow, provide some respite?
The AIM-listed group said the US Biomedical Advanced Research and Development Authority funds will support the Phase 3 development programme for ridinilazole, the company's precision new mechanism antibiotic for the treatment of C. difficile infection
Jefferies cut its rating on AstraZeneca to ‘hold’ from ‘buy’ but raised its target price to 6,200p from 5,942p
Analysts at Liberum believe the value of Cambian is "meaningfully greater" than what CareTech has offered for the firm but they see the benefits of the proposed merger
CEO Grigorios Siokas says aggressive sales and marketing pushed up quarterly profits
The company reports an earnings loss, but has enough resources to fund operations
Public offering of millions of shares called off by the biopharma company
Buyer WCAS has invested around US$9bn in companies in the healthcare sector
SkinBioTherapeutics' platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to the skin.
Cannabis stocks did an about-face on Wednesday as they soared in Canada after a host of positive news, after dropping sharply Tuesday.
The products in question are three natural sleep aids, named "Blissful Sleep", "Blissful Sleep Ex" and "Skullcap Serenity".
Small cap names on the move today are: Pain Therapeutics Inc (NASDAQ:PTIE), Casa Systems Inc's (NASDAQ:CASA), PetlQ Inc (NASDAQ:PETQ), Sigma Designs Inc (NASDAQ:SIGM).
The clinical-stage biopharma reported a net loss of US$1.26 per share, down from US$4.50 per share last year